These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 31951313

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.
    Li SS, Chen JJ, Zhang MM, Wang WX, Zhang WY, Ma C.
    Eur J Med Chem; 2024 May 05; 271():116425. PubMed ID: 38636129
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. S9, a novel anticancer agent, exerts its anti-proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton.
    Zhang C, Yang N, Yang CH, Ding HS, Luo C, Zhang Y, Wu MJ, Zhang XW, Shen X, Jiang HL, Meng LH, Ding J.
    PLoS One; 2009 May 05; 4(3):e4881. PubMed ID: 19293927
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovery of novel 1,3,5-triazine derivatives as potent inhibitor of cervical cancer via dual inhibition of PI3K/mTOR.
    Hu J, Zhang Y, Tang N, Lu Y, Guo P, Huang Z.
    Bioorg Med Chem; 2021 Feb 15; 32():115997. PubMed ID: 33440319
    [Abstract] [Full Text] [Related]

  • 11. CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway.
    Hung CM, Lin YC, Liu LC, Kuo SC, Ho CT, Way TD.
    Chem Biol Interact; 2016 Dec 25; 260():1-12. PubMed ID: 27769712
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
    Tang B, Wan D, Wang YJ, Yi QY, Guo BH, Liu YJ.
    Eur J Med Chem; 2018 Feb 10; 145():302-314. PubMed ID: 29331753
    [Abstract] [Full Text] [Related]

  • 15. Anti-proliferative effect of RCE-4 from Reineckia carnea on human cervical cancer HeLa cells by inhibiting the PI3K/Akt/mTOR signaling pathway and NF-κB activation.
    Bai C, Yang X, Zou K, He H, Wang J, Qin H, Yu X, Liu C, Zheng J, Cheng F, Chen J.
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun 10; 389(6):573-84. PubMed ID: 26935715
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and biological evaluation of imidazo[1,5-a]pyridine-benzimidazole hybrids as inhibitors of both tubulin polymerization and PI3K/Akt pathway.
    Kamal A, Rao AV, Nayak VL, Reddy NV, Swapna K, Ramakrishna G, Alvala M.
    Org Biomol Chem; 2014 Dec 28; 12(48):9864-80. PubMed ID: 25354805
    [Abstract] [Full Text] [Related]

  • 17. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
    Jiang JH, Pi J, Jin H, Cai JY.
    J Cell Biochem; 2019 Mar 28; 120(3):3736-3746. PubMed ID: 30229997
    [Abstract] [Full Text] [Related]

  • 18. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
    Xu J, Zuo D, Qi H, Shen Q, Bai Z, Han M, Li Z, Zhang W, Wu Y.
    Biomed Pharmacother; 2016 Mar 28; 78():308-321. PubMed ID: 26898456
    [Abstract] [Full Text] [Related]

  • 19. [Inhibition effect of active fraction from clove on PI3K/Akt/mTOR signaling pathway to induce apoptosis of human colon cancer HCT116 cells].
    Zhao G, Zhang D, Yang XH, Li XF, Liu MH.
    Zhongguo Zhong Yao Za Zhi; 2021 Mar 28; 46(5):1197-1204. PubMed ID: 33787115
    [Abstract] [Full Text] [Related]

  • 20. Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings.
    Li W, Sun Q, Song L, Gao C, Liu F, Chen Y, Jiang Y.
    Eur J Med Chem; 2017 Dec 01; 141():721-733. PubMed ID: 29107429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.